Kompanie Ltd
Send your deck

Biotech · Non-confidential deck

Non-confidential biotech decks that interest without disclosing.

The non-confidential deck opens conversations with investors and pharma partners. It must make the opportunity compelling while leaving out anything you cannot yet share.

See packages, from $3,500Get a written audit, $1,500

Fixed prices. No calls: you brief us in writing and comment in writing.

Teaser

What we can share before an agreement

Illustration only. Any figures are invented for this sample slide.

Who reads it

Investors and business development teams screening many opportunities.

Turnaround

5 business days for a design rebuild; 3 business days for an audit.

How it differs

How a non-confidential deck differs from a general pitch deck

A general startup deck goes to a chosen reader. A non-confidential deck is written on the assumption that anyone may read it, including competitors, because it will be forwarded. Its goal is a confidentiality agreement, not an investment decision. Every fact on it must be public or cleared for release, so the craft is choosing headlines that show quality without revealing structures, targets or unpublished data. Pharma business development readers screen many of these, so stage, modality and ask must be clear within the first few slides.

Slide by slide

What goes in a non-confidential deck

  1. 01

    Company in one line

    What you are developing and for whom.

  2. 02

    Need

    The unmet medical need.

  3. 03

    Approach

    Described without confidential detail.

  4. 04

    Data headlines

    Public or publishable results only.

  5. 05

    Pipeline overview

    Stages, without proprietary specifics.

  6. 06

    Team

    Scientific and business leadership.

  7. 07

    What you are seeking

    Investment, partnership or both.

  8. 08

    Contact

    Who to reach.

The questions behind every slide

What readers of a non-confidential deck ask

Each answer names the slide or document where it belongs. If a question has no home in your deck, the reader will ask it in writing, or stop reading.

  1. 1

    What stage is the lead asset, and what is the next data point?

    The data headlines and pipeline overview slides should answer both in one line each.

  2. 2

    What modality is it?

    The approach slide should name the modality, and the target class if your counsel allows.

  3. 3

    Is the asset open to licensing, co-development or regional rights?

    The what-you-are-seeking slide should name the deal structures you will consider.

  4. 4

    Which territories are still available?

    The what-you-are-seeking slide, listing territories open for discussion.

  5. 5

    What patent protection exists, at a high level?

    One line on the approach or pipeline slide giving filing status only, as your counsel approves.

  6. 6

    How does it differ from the standard of care and competing programs?

    The need slide, with one differentiation statement that reveals no proprietary detail.

  7. 7

    What will we see after signing a confidentiality agreement?

    The contact slide should list what the confidential package contains.

  8. 8

    Who has funded the company so far?

    The team or company slide, naming investors only with their permission.

Headline rewrites

Slide titles that say something.

A reader skims headlines first. A label tells them the topic; a sentence tells them the point. Bracketed figures are placeholders for your own numbers.

Before

Our approach

After

A [modality] that reaches [target class] without [current limitation]

Before

Data

After

Published [model] data show [effect], with the full set available under a confidentiality agreement

Before

Partnering

After

We seek a partner for [program] development in [territory] from [stage]

What we fix

Faults we see in non-confidential deck drafts

  • Confidential details slipping into a public deck.

  • So little detail that nothing is credible.

  • No clear ask.

What you receive

Documents we produce

  • Non-confidential deck
  • Matching confidential deck
  • One-page summary

Every file is delivered editable, in PowerPoint, Google Slides or Keynote, with a PDF for sending. A non-confidential deck rebuild starts at $3,500; the full Raise Set with one-pager and teaser is $10,000.

Format

Length, versions and appendix

Length
Usually 8 to 15 slides, shorter than the full deck.
Send-ahead version
Send a PDF that can be forwarded freely, with a short email and a one-page summary. Assume it will reach readers beyond the first one.
Presented version
Often used as a short opener in partnering meetings, ending with a request to sign a confidentiality agreement.

What belongs in the appendix

  • List of public publications and posters
  • High-level patent filing status
  • Development stage timeline
  • Team biographies
  • Contact details

Before you send it

Non-confidential deck checklist

  • Every fact is public, published or cleared for release by your counsel.
  • No target name, structure or sequence appears unless it is already public.
  • Unpublished data is reduced to headlines your counsel has approved.
  • The file name and footer say Non-confidential.
  • Speaker notes, hidden slides and file metadata are removed.
  • The ask names deal types and territories.
  • One named person is given as the contact.
  • The matching confidential deck keeps the same order and labels.

Glossary

Terms used in a non-confidential deck

Confidential disclosure agreement (CDA)
A contract signed before sharing private data, limiting how the receiver may use and share it.
Non-confidential summary
A one- or two-page overview of an asset or company that can be forwarded freely.
Search and evaluation
The team at a pharma company that screens outside assets and companies for licensing or acquisition.
Data room
A secure online folder where confidential documents are shared in stages during diligence.
Term sheet
A non-binding outline of the main deal terms, agreed before the full contract is drafted.
Modality
The type of therapy, such as small molecule, antibody, cell therapy or gene therapy.

Your written brief

What to send us for a non-confidential deck

No call needed. Send what you have; missing items are listed in our written reply, and nothing is invented to fill a gap.

  • 01Your full confidential deck
  • 02A list of what is already public: papers, posters, patent filings
  • 03Your counsel's guidance on what may be disclosed
  • 04Deal types and territories you are open to
  • 05Data headlines cleared for release
  • 06Team biographies
  • 07One contact person and their details

Packages

Four packages, fixed prices.

Deck Audit

$1,500

3 business days

A written verdict on the deck you have, before you send it to anyone.

  • Slide-by-slide notes inside your file
  • The fixes that matter most, in order
  • Story, numbers and design, each assessed
  • The investor questions your deck leaves open

One deck, up to 20 slides. No redesign included.

Choose Deck Audit
Most chosen

Investor Finish

$3,500

5 business days

Your draft, rebuilt to investor standard. Design only.

  • Up to 15 slides rebuilt
  • Charts redrawn from your data
  • Your brand applied throughout
  • One written revision round
  • Editable PowerPoint, Google Slides or Keynote

Design only: your wording and slide order stay as they are.

Choose Investor Finish

Finish + Story

$6,500

8 business days

We restructure the argument, rewrite the headlines, then rebuild the deck.

  • Up to 20 slides
  • Narrative restructured from your draft and notes
  • Headlines rewritten as full-sentence points
  • Send-ahead PDF version
  • Two written revision rounds

We work from your facts. No market research or financial modeling.

Choose Finish + Story

Raise Set

$10,000

12 business days

Everything a raise needs, in one matching set.

  • Up to 30 slides plus appendix
  • Investor one-pager
  • Short teaser version for cold outreach
  • Three written revision rounds
  • All source files

No investor introductions, fundraising or legal advice.

Choose Raise Set

Not included in any package: Calls or meetings · Market research · Financial modeling or valuation · Investor introductions · Fundraising, legal or securities advice. Extra slides and extra revision rounds are quoted in writing before we start them.

Questions, answered.

Who decides what is confidential?+

You and your counsel. We design only what you approve.

How much does a pitch deck cost here?+

A written Deck Audit is $1,500. Investor Finish, a design rebuild of up to 15 slides, is $3,500. Finish + Story, with the argument restructured, is $6,500. Raise Set, up to 30 slides with a one-pager and teaser, is $10,000.

How long does it take?+

Three business days for an audit, five for Investor Finish, eight for Finish + Story and twelve for Raise Set, counted from payment and a complete brief.

Is there a call?+

No. No package includes a call or meeting. You brief us in writing and comment in writing.

What do I need to send?+

Your draft deck in any editable format, or notes if you chose a package with writing, plus a few lines on who will read it and what you are asking for.

How do I pay?+

By card, through a secure payment link we send once scope and delivery date are confirmed in writing.

More decks in Biotech

All 4 Biotech decks

Other categories

Pitch deck design for biotech companies: science, pipeline and milestones made clear for investors who are not all specialists. Fixed packages from $3,500.

Further reading

Sources we read when writing this page. General information only; not legal, tax or investment advice.

Have a draft? Send it today.

Choose a package, link your deck and write a few lines about who it is for. You get scope, a delivery date and a payment link in writing.

Start in writingSee prices
Non-Confidential Biotech Deck Design